Role of the Pharmacist Caring for People at Risk of or Living with HIV in Canada

Overview

Journal Can Pharm J (Ott)

Specialty Pharmacology

Date 2024 Sep 23

PMID 39310805

Authors

Stacey Tkachuk

Erin Ready

Shanna Chan

Jennifer Hawkes

Tracy Janzen Cheney

Jeff Kapler

Denise Kreutzwiser

Linda Akagi

Michael Coombs

Pierre Giguere

Christine Hughes

Deborah Kelly

Sheri Livingston

Dominic Martel

Mark Naccarato

Salin Nhean

Carley Pozniak

Tasha Ramsey

Linda Robinson

Jonathan Smith

Jaris Swidrovich

Jodi Symes

Deborah Yoong

Alice Tseng

Affiliations

Soon will be listed here.

References

Landry S, Chen C, Patel N, Tseng A, Lalonde R, Thibeault D . Therapeutic drug monitoring in treatment-experienced HIV-infected patients receiving darunavir-based salvage regimens: A case series. Antiviral Res. 2018; 152:111-116. DOI: 10.1016/j.antiviral.2018.02.010. View

Schaefer R, Gregson S, Fearon E, Hensen B, Hallett T, Hargreaves J . HIV prevention cascades: A unifying framework to replicate the successes of treatment cascades. Lancet HIV. 2020; 6(1):e60-e66. PMC: 7025885. DOI: 10.1016/S2352-3018(18)30327-8. View

Connor E, Sperling R, Gelber R, Kiselev P, Scott G, OSullivan M . Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994; 331(18):1173-80. DOI: 10.1056/NEJM199411033311801. View

Nishijima T, Gatanaga H, Teruya K, Mizushima D, Aoki T, Watanabe K . Skin rash induced by ritonavir-boosted darunavir is common, but generally tolerable in an observational setting. J Infect Chemother. 2014; 20(4):285-7. DOI: 10.1016/j.jiac.2014.01.004. View

McNicholl I, Gandhi M, Hare C, Greene M, Pierluissi E . A Pharmacist-Led Program to Evaluate and Reduce Polypharmacy and Potentially Inappropriate Prescribing in Older HIV-Positive Patients. Pharmacotherapy. 2017; 37(12):1498-1506. DOI: 10.1002/phar.2043. View

Kreutzwiser D, Sheehan N, Dayneka N, Lemire B, Wong A, Samson L . Therapeutic drug monitoring guided raltegravir dosing for prevention of vertical transmission in a premature neonate born to a woman living with perinatally acquired HIV. Antivir Ther. 2017; 22(6):545-549. DOI: 10.3851/IMP3139. View

So-Armah K, Benjamin L, Bloomfield G, Feinstein M, Hsue P, Njuguna B . HIV and cardiovascular disease. Lancet HIV. 2020; 7(4):e279-e293. PMC: 9346572. DOI: 10.1016/S2352-3018(20)30036-9. View

Nozza S, Timelli L, Saracino A, Gianotti N, Lazzaretti C, Tavelli A . Decrease in Incidence Rate of Hospitalizations Due to AIDS-Defining Conditions but Not to Non-AIDS Conditions in PLWHIV on cART in 2008-2018 in Italy. J Clin Med. 2021; 10(15). PMC: 8347382. DOI: 10.3390/jcm10153391. View

Fischetti B, Shah K, Taft D, Berkowitz L, Bakshi A, Cha A . Real-World Experience With Higher-Than-Recommended Doses of Lamivudine in Patients With Varying Degrees of Renal Impairment. Open Forum Infect Dis. 2018; 5(10):ofy225. PMC: 6171568. DOI: 10.1093/ofid/ofy225. View

10.

Cheng Z, Lin P, Cheng N . HBV/HIV Coinfection: Impact on the Development and Clinical Treatment of Liver Diseases. Front Med (Lausanne). 2021; 8:713981. PMC: 8524435. DOI: 10.3389/fmed.2021.713981. View

11.

Bruce R, Merlin J, Lum P, Ahmed E, Alexander C, Corbett A . 2017 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With HIV. Clin Infect Dis. 2017; 65(10):e1-e37. PMC: 5848240. DOI: 10.1093/cid/cix636. View

12.

Brunetta J, Baril J, de Wet J, Fraser C, Rubin G, Thomas R . Cross-sectional comparison of age- and gender-related comorbidities in people living with HIV in Canada. Medicine (Baltimore). 2022; 101(28):e29850. PMC: 11132354. DOI: 10.1097/MD.0000000000029850. View

13.

Lam C, Landry S, Moussa G, Sakr D, Varinot G, Mousseau K . Pharmacotherapeutic Interventions in People Living With HIV Undergoing Solid Organ Transplantation: A Scoping Review. Transplant Direct. 2023; 9(2):e1441. PMC: 9886517. DOI: 10.1097/TXD.0000000000001441. View

14.

Alvarnas J, Zaia J, Forman S . How I treat patients with HIV-related hematological malignancies using hematopoietic cell transplantation. Blood. 2017; 130(18):1976-1984. DOI: 10.1182/blood-2017-04-551606. View

15.

Madden V, Parker R, Goodin B . Chronic pain in people with HIV: a common comorbidity and threat to quality of life. Pain Manag. 2020; 10(4):253-260. PMC: 7421257. DOI: 10.2217/pmt-2020-0004. View

16.

Heath S, Bansal A . Mpox infection in people living with HIV. AIDS. 2023; 37(4):701-703. DOI: 10.1097/QAD.0000000000003495. View

17.

Hill-Taylor B, Walsh K, Stewart S, Hayden J, Byrne S, Sketris I . Effectiveness of the STOPP/START (Screening Tool of Older Persons' potentially inappropriate Prescriptions/Screening Tool to Alert doctors to the Right Treatment) criteria: systematic review and meta-analysis of randomized controlled studies. J Clin Pharm Ther. 2016; 41(2):158-69. DOI: 10.1111/jcpt.12372. View

18.

Young J, Ablona A, Klassen B, Higgins R, Kim J, Lavoie S . Implementing community-based Dried Blood Spot (DBS) testing for HIV and hepatitis C: a qualitative analysis of key facilitators and ongoing challenges. BMC Public Health. 2022; 22(1):1085. PMC: 9158154. DOI: 10.1186/s12889-022-13525-x. View

19.

Hughes C, Yoong D, Giguere P, Hull M, Tan D . Canadian guideline on HIV preexposure prophylaxis and nonoccupational postexposure prophylaxis for pharmacists. Can Pharm J (Ott). 2019; 152(2):81-91. PMC: 6410427. DOI: 10.1177/1715163519826171. View

20.

Kendall C, Shoemaker E, Boucher L, Rolfe D, Crowe L, Becker M . The organizational attributes of HIV care delivery models in Canada: A cross-sectional study. PLoS One. 2018; 13(6):e0199395. PMC: 6010295. DOI: 10.1371/journal.pone.0199395. View